Advances in Parkinson’s Disease
A special issue of Neurology International (ISSN 2035-8377).
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 6492
Special Issue Editor
Interests: movement disorders; Parkinson’s disease; neurodegenerative diseases; biomarkers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Parkinson’s disease (PD) is a complex progressive neurodegenerative disorder causing motor and non-motor symptoms that result in disability, loss of patient autonomy, and caregiver burden. The correct diagnosis of PD is important for prognostic and therapeutic reasons and is essential for clinical research. Although there is no specific diagnostic marker of PD at present, ongoing research aims to develop diagnostic biomarkers for use in the clinical and preclinical stages of PD. This issue aims to summarize the most recent advances in “Clinical Diagnostics, Biomarkers and Pathology in Parkinson’s Disease”.
Studies focused on identifying diagnostic markers (clinical, neuroimaging, molecular, genetic, pathological, etc.) of PD or that enable the identification or prediction of the development of PD-related complications (cognitive impairment, dementia, psychosis, impulse control disorders, freezing of gait, etc.) are considered of interest.
I hope this Special Issue is of interest to you, and I encourage you to contribute a manuscript. Many thanks in advance.
Dr. Diego Santos-García
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- clinical
- diagnosis
- Parkinson’s disease
- pathology